NeuroVentures
11
16M
8
0.50
0.27
1
- Stages of investment
- Areas of investment
Summary
NeuroVentures is the famous VC, which was founded in 2000. The fund was located in North America if to be more exact in United States. The main office of represented VC is situated in the Charlottesville.
The fund is constantly included in less than 2 deals per year. The higher amount of exits for fund were in 2005. The high activity for fund was in 2004. The typical startup value when the investment from NeuroVentures is 5-10 millions dollars. Deals in the range of 10 - 50 millions dollars are the general things for fund. Opposing the other organizations, this NeuroVentures works on 19 percentage points less the average amount of lead investments.
The overall number of key employees were 1.
For fund there is a match between the location of its establishment and the land of its numerous investments - United States. The fund has exact preference in a number of founders of portfolio startups. Moreover, a startup needs to be at the age of 4-5 years to get the investment from the fund. Among the most successful fund investment fields, there are Biopharma, Neuroscience. Among the various public portfolio startups of the fund, we may underline NeurAxon, BrainCells, Kadmus Pharmaceuticals
The typical case for the fund is to invest in rounds with 5-6 participants. Despite the NeuroVentures, startups are often financed by Ventures West, H.I.G. Capital, Oxford Bioscience Partners. The meaningful sponsors for the fund in investment in the same round are Ventures West, Oxford Bioscience Partners, H.I.G. Capital. In the next rounds fund is usually obtained by Ventures West, OrbiMed, New Enterprise Associates.
Investments analytics
Analytics
- Total investments
- 11
- Lead investments
- 0
- Exits
- 1
- Rounds per year
- 0.50
- Follow on index
- 0.27
- Investments by industry
- Biotechnology (9)
- Health Care (6)
- Medical (3)
- Neuroscience (3)
- Therapeutics (3) Show 4 more
- Investments by region
-
- United States (8)
- Canada (3)
- Peak activity year
- 2004
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 22
- Avg. valuation at time of investment
- 20M
- Group Appearance index
- 0.91
- Avg. company exit year
- 9
- Avg. multiplicator
- 5.16
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| Scion Pharmaceuticals | 15 Jul 2002 | Biotechnology, Medical | Early Stage Venture | 17M | United States, Massachusetts, Boston |
Similar funds
By same location
By same geo focus
By doing lead investments
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.